Daehan New Pharm Co., Ltd.

A054670

KR7054670005

Pharmaceuticals

End-of-day quote Korea S.E. Other stock markets 18:00:00 2024-05-08 EDT			5-day change	1st Jan Change
8,050 ^KRW	-0.62%		0.00%	-11.05%

2023	Daehan New Pharm Co., Ltd.(KOSDAQ:A054670) dropped from S&P Global BMI Index	CI
2017	Daehan New Pharm Co., Ltd. cancelled the acquisition of additional 3.5% stake in Baverstock GmbH from Kuat Rafikly Oraziman.	CI

Daehan New Pharm Co., Ltd.(KOSDAQ:A054670) added to Russell Global Index

June 29, 2015 at 12:00 am

Latest news about Daehan New Pharm Co., Ltd.

Daehan New Pharm Co., Ltd.(KOSDAQ:A054670) dropped from S&P Global BMI Index	23-09-18	CI
Daehan New Pharm Co., Ltd. cancelled the acquisition of additional 3.5% stake in Baverstock GmbH from Kuat Rafikly Oraziman.	17-11-22	CI
Baverstock GmbH acquired 6.97% stake in BNG Energy BV from Daehan New Pharm Co., Ltd. for KRW 7.3 billion.	16-11-22	CI
Daehan New Pharm Co., Ltd. agreed to acquired additional 3.5% stake in Baverstock GmbH from Kuat Rafikly Oraziman for KRW 5.6 billion.	16-11-22	CI
Daehan New Pharm Co., Ltd. acquired an additional 8% stake in Baverstock GmbH for KRW 12.9 billion.	15-09-21	CI
Daehan New Pharm Co., Ltd.(KOSDAQ:A054670) added to Russell Global Index	15-06-29	CI
Daehan New Pharm Co., Ltd.(KOSDAQ:A054670) added to MSCI Acwi + Frontier Markets(acwi Fm) All Cap Index	15-06-01	CI
Daehan New Pharm Co., Ltd. announced that it has received KRW 5 billion in funding.	12-05-24	CI
Daehan New Pharm Co., Ltd. announced that it expects to receive KRW 5 billion in funding.	12-05-23	CI

Chart Daehan New Pharm Co., Ltd.

Duration

Period

More charts

Daehan New Pharm Co., Ltd. is a Korea-based company specialized in the provision of pharmaceutical products. The Company provides two categories of products: human pharmaceutical products and animal pharmaceutical products. Its human pharmaceutical products include analgesics, anti-inflammatory drugs, antipyretics, antibacterial, antidiabetics, antihistamines, antineoplastics, immunosuppressants, cardiovascular drugs, gastrointestinal drugs, muscle relaxants, antispasmodics and others. Its animal pharmaceutical products include antibacterial, coccidiostats, antihelmintics, probiotic, nutrients, metabolic stimulants, disinfectants, functional supplement feeds, liver tonics, antihelmintics and others for poultries, cattle, sheep, swine and fishes.

Sector

Pharmaceuticals

Calendar

2024-05-13 - Q1 2024 Earnings Release (Projected)

More about the company

Sector Other Pharmaceuticals

	1st Jan change	Capi.
DAEHAN NEW PHARM CO., LTD.	-11.05%	82.75M
ELI LILLY AND COMPANY	+32.36%	695B
NOVO NORDISK A/S	+26.51%	568B
JOHNSON & JOHNSON	-4.40%	361B
MERCK & CO., INC.	+19.46%	330B
ABBVIE INC.	+3.50%	283B
ASTRAZENECA PLC	+16.34%	239B
NOVARTIS AG	+6.68%	204B
ROCHE HOLDING AG	-9.08%	198B
AMGEN INC.	+8.62%	168B

Other Pharmaceuticals